Which nerve block eases hip surgery pain better?

NCT ID NCT07771829

First seen Aug 18, 2026 ยท Last updated Aug 18, 2026

Summary

This trial compares two ultrasound-guided nerve block techniques for pain control after total hip replacement surgery. One technique, the QLESP block, uses a single injection to target two areas, while the other combines two blocks (PENG and LFCN) to target nerves around the hip and outer thigh. Participants are randomly assigned to receive one of the two blocks after surgery. The study measures pain scores, opioid use, leg movement recovery, time to first walk, and hospital stay length to see which approach offers better pain relief and faster recovery.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Two nerve block techniques: QLESP block (single injection targeting two areas) versus PENG+LFCN block (two injections targeting hip and thigh nerves), using the local anesthetic ropivacaine.
What this could lead to
If one nerve block proves better, it could lead to improved pain control and faster recovery after hip replacement surgery, reducing the need for opioids.
What could go wrong
The trial is relatively small and early-stage, so results may not apply to all patients. Nerve blocks carry risks like infection, bleeding, or nerve damage, and pain relief may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHROPLASTY TOTAL HIP REPLACEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, 430022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.